We are live on ! Find out more
ETNB

89bio
ETNB

Delisted

ETNB was delisted on the 29th of October, 2025.

Back to rankings

34 hedge funds and large institutions have $275M invested in 89bio in 2019 Q4 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

75.72% more ownership

Funds ownership: 0% → 75.72% (+76%)

Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
34
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$111M
2
RCM
RA Capital Management
Massachusetts
+$88M
3
VMI
VHCP Management III
New York
+$26.7M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$25.7M
5
EAM
Eventide Asset Management
Massachusetts
+$9.74M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$105M +$111M +4,004,442 New
RCM
2
RA Capital Management
Massachusetts
$83.1M +$88M +3,161,214 New
VMI
3
VHCP Management III
New York
$25.2M +$26.7M +958,765 New
Wellington Management Group
4
Wellington Management Group
Massachusetts
$24.3M +$25.7M +922,999 New
EAM
5
Eventide Asset Management
Massachusetts
$9.2M +$9.74M +350,000 New
Franklin Resources
6
Franklin Resources
California
$6.57M +$6.96M +250,000 New
BlackRock
7
BlackRock
New York
$4.82M +$5.1M +183,322 New
Alyeska Investment Group
8
Alyeska Investment Group
Illinois
$3.14M +$3.32M +119,444 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$2.43M +$2.57M +92,477 New
LGM
10
Logos Global Management
California
$2.28M +$2.41M +86,591 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.47M +$1.56M +56,033 New
VMI
12
VHCP Management II
New York
$1.08M +$1.15M +41,235 New
Northern Trust
13
Northern Trust
Illinois
$784K +$830K +29,814 New
Charles Schwab
14
Charles Schwab
California
$745K +$789K +28,336 New
Morgan Stanley
15
Morgan Stanley
New York
$724K +$766K +27,542 New
SSA
16
Schonfeld Strategic Advisors
New York
$705K +$747K +26,840 New
Goldman Sachs
17
Goldman Sachs
New York
$600K +$635K +22,836 New
State Street
18
State Street
Massachusetts
$549K +$581K +20,864 New
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$503K +$532K +19,127 New
AC
20
Athanor Capital
New York
$281K +$298K +10,696 New
LCM
21
Landscape Capital Management
New Jersey
$202K +$214K +7,695 New
UBS Group
22
UBS Group
Switzerland
$163K +$172K +6,193 New
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$118K +$125K +4,487 New
New York State Common Retirement Fund
24
New York State Common Retirement Fund
New York
$103K +$109K +3,900 New
AIG
25
American International Group
New York
$48K +$51.2K +1,839 New
1
2

ETNB Hedge Fund Activity: Q4 2019 in Review

34 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in 89bio (ETNB) for Q4 2019, worth a combined $275M.

Buyers outnumbered sellers: 34 funds opened new ETNB positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $111M.

  • 34 institutional investors held 89bio (ETNB) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $275M of 89bio stock for Q4 2019.
  • 34 funds opened new 89bio positions in Q4 2019 and 0 closed out, a net change of +34 holders.
  • The largest 89bio buyer in Q4 2019 was OrbiMed, an estimated $111M added.

Based on aggregated 13F filings for Q4 2019.